Investigating a pathogenic role for TXNDC5 in tumors

International Journal of Oncology

Volumn 43, Issue 6, 2013, Pages 1871-1884

  Chang, Xiaotian ^a   Xu, Bing ^a   Wang, Lin ^b   Wang, Yao ^a   Wang, Yuejian ^a   Yan, Suhua ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Cell proliferation; Susceptibility; Tumor; TXNDC5

Indexed keywords

SMALL INTERFERING RNA;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; CERVICAL SQUAMOUS CELL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE; GENE EXPRESSION; GENE LOCUS; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; OVARIAN PAPILLARY SEROUS CARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; TXNDC5 GENE; UNDIFFERENTIATED CARCINOMA; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HELA CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN DISULFIDE-ISOMERASES; RECTAL NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 84891942766     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2123     Document Type: Article

References (17)

1. Edman JC, Ellis L, Blacher RW, Roth RA and Rutter WJ: Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature 317: 267-270, 1985.
2. Freedman RB, Hirst TR and Tuite MF: Protein disulphide isomerase: building bridges in protein folding. Trends Biochem Sci 19: 331-336, 1994.
3. Knoblach B, Keller BO, Groenendyk J, Aldred S, Zheng J, Lemire BD, Li L and Michalak M: ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins. Mol Cell Proteomics 2: 1104-1109, 2003.
4. Charlton HK, Webster J, Kruger S, Simpson F, Richards AA and Whitehead JP: ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signaling. Biochem Biophys Res Commun 392: 234-239, 2010.
5. Sullivan DC, Huminiecki L, Moore JW, Boyle JJ, Poulsom R, Creamer D, Barker J and Bicknell R: EndoPDI, a novel protein - disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor. J Biol Chem 47: 47079-47088, 2003.
6. Wang Y, Ma Y, Lü B, Xu E, Huang Q and Lai M: Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study. Exp Biol Med (Maywood) 232: 1152-1159, 2007.
7. Vincent EE, Elder DJ, Phillips L, Heesom KJ, Pawade J, Luckett M, Sohail M, May MT, Hetzel MR and Tavaré JML: Overexpression of the TXNDC5 protein in non-small cell lung carcinoma. Anticancer Res 31: 1577-1582, 2011.
8. Zhang L, Hou Y, Li N, Wu K and Zhai J: The influence of TXNDC5 gene on gastric cancer cell. J Cancer Res Clin Oncol 136: 1497-1505, 2010.
9. The International HapMap Consortium: Integrating ethics and science in the International HapMap Project. Nat Rev Genet 5: 467-475, 2004.
10. Barrett JC, Fry B, Maller J and Daly MJ: Haploview analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
11. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L and Shi Y: A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 19: 519-523, 2009.
12. Policastro LL, Ibañez IL, Notcovich C, Durán HA and Podhajcer OL: The tumor microenvironment: characterization, redox considerations and novel approaches for ROS-targeted gene therapy. Antioxid Redox Signal 19: 854-895, 2012.
13. Dang CV: Links between metabolism and cancer. Genes Dev 26: 877-890, 2012.
14. Wang L, Zheng Y, Xu H, Yan X and Chang X: Investigate pathogenic mechanism of TXNDC5 in rheumatoid arthritis. PLoS One 8: e53301, 2013.
15. Jeong KH, Shin MK, Uhm YK, Kim HJ, Chung JH and Lee MH: Association of TXNDC5 gene polymorphisms and susceptibility to nonsegmental vitiligo in the Korean population. Br J Dermatol 162: 759-764, 2010.
16. Lin SH, Liu CM, Liu YL, Shen-Jang Fann C, Hsiao PC, Wu JY, Hung SI, Chen CH, Wu HM, Jou YS, Liu SK, Hwang TJ, Hsieh MH, Chang CC, Yang WC, Lin JJ, Chou FH, Faraone SV, Tsuang MT, Hwu HG and Chen WJ: Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p. Genes Brain Behav 8: 785-794, 2009.
17. Chang X, Zhao Y, Yan X, Pan J, Fang K and Wang L: Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis. Arthritis Res Ther 13: R12, 2011.